Risk stratification and prognosis determination using 18F-FDG PET imaging in endometrial cancer patients: A systematic review and meta-analysis

Jemal, 2010, Cancer statistics, 2010, CA Cancer J Clin, 60, 277, 10.3322/caac.20073 Marnitz, 2012, Current therapy of patients with endometrial carcinoma. A critical review, Strahlenther Onkol, 188, 12, 10.1007/s00066-011-0004-0 Chi, 2008, The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology, Int J Gynecol Cancer, 18, 269, 10.1111/j.1525-1438.2007.00996.x Maneschi, 2012, Endometrial cancer: prognostic significance of risk classification based on pre-intraoperative findings, Arch Gynecol Obstet, 285, 521, 10.1007/s00404-011-2004-9 Turan, 2012, What is the impact of cervical invasion on lymph node metastasis in patients with stage IIIC endometrial cancer?, Arch Gynecol Obstet, 285, 1119, 10.1007/s00404-011-2030-7 Ansari, 2013, Sentinel node biopsy in endometrial cancer: systematic review and meta-analysis of the literature, Eur J Gynaecol Oncol, 34, 387 Antonsen, 2013, MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer — a multicenter prospective comparative study, Gynecol Oncol, 128, 300, 10.1016/j.ygyno.2012.11.025 Kadkhodayan, 2013, Accuracy of 18-F-FDG PET imaging in the follow up of endometrial cancer patients: systematic review and meta-analysis of the literature, Gynecol Oncol, 128, 397, 10.1016/j.ygyno.2012.10.022 Sadeghi, 2012, Accuracy of 18F-FDG PET/CT for diagnosing inguinal lymph node involvement in penile squamous cell carcinoma: systematic review and meta-analysis of the literature, Clin Nucl Med, 37, 436, 10.1097/RLU.0b013e318238f6ea Kakhki, 2013, Diagnostic performance of fluorine 18 fluorodeoxyglucose positron emission tomography imaging for detection of primary lesion and staging of endometrial cancer patients: systematic review and meta-analysis of the literature, Int J Gynecol Cancer, 23, 1536, 10.1097/IGC.0000000000000003 Sadeghi, 2013, Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography imaging in uterine sarcomas: systematic review and meta-analysis of the literature, Int J Gynecol Cancer, 23, 1349, 10.1097/IGC.0b013e3182a20e18 Sharma, 2012, Role of FDG PET-CT in detecting recurrence in patients with uterine sarcoma: comparison with conventional imaging, Nucl Med Commun, 33, 185, 10.1097/MNM.0b013e32834e41a6 Parmar, 1998, Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints, Stat Med, 17, 2815, 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8 von Elm, 2008, The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, J Clin Epidemiol, 61, 344, 10.1016/j.jclinepi.2007.11.008 DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 Zamora, 2006, Meta-DiSc: a software for meta-analysis of test accuracy data, BMC Med Res Methodol, 6, 31, 10.1186/1471-2288-6-31 Tsujikawa, 2011, Functional oestrogen receptor alpha imaging in endometrial carcinoma using 16alpha-[(1)(8)F]fluoro-17beta-oestradiol PET, Eur J Nucl Med Mol Imaging, 38, 37, 10.1007/s00259-010-1589-8 Tsujikawa, 2008, Uterine tumors: pathophysiologic imaging with 16alpha-[18F]fluoro-17beta-estradiol and 18F fluorodeoxyglucose PET — initial experience, Radiology, 248, 599, 10.1148/radiol.2482071379 Nakamura, 2011, The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer, Gynecol Oncol, 123, 82, 10.1016/j.ygyno.2011.06.026 Nakamura, 2010, The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer, Int J Gynecol Cancer, 20, 110, 10.1111/IGC.0b013e3181c3a288 Chung, 2011, Post-treatment [18F]FDG maximum standardized uptake value as a prognostic marker of recurrence in endometrial carcinoma, Eur J Nucl Med Mol Imaging, 38, 74, 10.1007/s00259-010-1614-y Torizuka, 2006, FDG PET for the assessment of myometrial infiltration in clinical stage I uterine corpus cancer, Nucl Med Commun, 27, 481, 10.1097/00006231-200606000-00002 Suzuki, 2007, Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer, Int J Gynecol Cancer, 17, 890, 10.1111/j.1525-1438.2007.00859.x Tsujikawa, 2009, Functional images reflect aggressiveness of endometrial carcinoma: estrogen receptor expression combined with 18F-FDG PET, J Nucl Med, 50, 1598, 10.2967/jnumed.108.060145 Lee, 2011, Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer, Nuklearmedizin, 50, 204, 10.3413/nukmed-0375-10-12 Kitajima, 2012, Prognostic significance of SUVmax (maximum standardized uptake value) measured by [(1)(8)F]FDG PET/CT in endometrial cancer, Eur J Nucl Med Mol Imaging, 39, 840, 10.1007/s00259-011-2057-9 Liu, 2012, Metabolic tumor volume by 18F-FDG PET/CT is prognostic for stage IVB endometrial carcinoma, Gynecol Oncol, 125, 566, 10.1016/j.ygyno.2012.03.021 Nakamura, 2013, The preoperative SUVmax is superior to ADCmin of the primary tumour as a predictor of disease recurrence and survival in patients with endometrial cancer, Eur J Nucl Med Mol Imaging, 40, 52, 10.1007/s00259-012-2240-7 Antonsen, 2013, SUVmax of (18)FDG PET/CT as a predictor of high-risk endometrial cancer patients, Gynecol Oncol, 129, 298, 10.1016/j.ygyno.2013.01.019 Chung, 2013, Prognostic value of preoperative metabolic tumor volume measured by (1)(8)F-FDG PET/CT and MRI in patients with endometrial cancer, Gynecol Oncol, 130, 446, 10.1016/j.ygyno.2013.06.021 Walentowicz-Sadlecka, 2013, SUVmax measured by 18F FDG PET/CT in the primary tumor in relation to clinical and pathological features of endometrial cancer, Ginekol Pol, 84, 748, 10.17772/gp/1634